| Article ID | Journal | Published Year | Pages | File Type |
|---|---|---|---|---|
| 8659122 | Diabetes & Metabolic Syndrome: Clinical Research & Reviews | 2016 | 27 Pages |
Abstract
We found that elevated level of vistafin was an independent predictor for declined numerous of non-classical EPCs labeled as CD14+CD309+ and CD14+CD309+Tie2+, whereas CD34+ subsets of EPCs did not associate with vistafin level in T2DM individuals.
Related Topics
Health Sciences
Medicine and Dentistry
Cardiology and Cardiovascular Medicine
Authors
Alexander E. Berezin, Tatyana A Samura, Alexander A. Kremzer, Tatyana A Berezina, Yulia V. Martovitskaya, Elena A Gromenko,